08/12/2025
6:15 AM | Passage Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2025
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2025
4:44 PM | ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
| Form SCHEDULE 13D/A | |
07/24/2025
5:12 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2025
4:28 PM | ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
| Form SCHEDULE 13D/A | |
07/21/2025
4:33 PM | ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2025
7:17 PM | ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/14/2025
6:01 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2025
7:06 PM | ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
| Form SCHEDULE 13D/A | |
07/07/2025
5:02 PM | ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2025
4:10 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for PASG and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Passage Bio and its competitors with MarketBeat's FREE daily newsletter. |
06/24/2025
5:48 PM | ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2025
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2025
8:41 PM | Kapadia Sandip (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
6:26 PM | Kassberg Thomas Richard (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
6:27 PM | Passage Bio (Issuer)
Sondhi Dolan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
6:28 PM | Islam Saqib (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
6:29 PM | Passage Bio (Issuer)
Porter Derrell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
6:30 PM | Countouriotis Athena (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
6:31 PM | GOWEN MAXINE (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
6:15 AM | Passage Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2025
6:48 PM | ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
| Form SCHEDULE 13D/A | |
04/24/2025
4:38 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:10 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2025
6:00 AM | Passage Bio (Filer)
| Form DEF 14A | |
04/16/2025
6:01 AM | Passage Bio (Filer)
| Form DEFA14A | |
04/16/2025
6:02 AM | Passage Bio (Filer)
| Form ARS | |
04/15/2025
4:40 PM | ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2025
6:15 AM | Passage Bio (Filer)
| Form PRE 14A | |
03/18/2025
4:11 PM | Cale Edgar B. (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:11 PM | Chou William (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:12 PM | Borthwick Kathleen (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
5:05 AM | Passage Bio (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/05/2025
5:09 AM | Passage Bio (Filer)
| Form 424B5 | |
03/04/2025
6:15 AM | Passage Bio (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2025
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
8:01 AM | Lynx1 Capital Management LP (Filed by)
Passage Bio (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
3:21 PM | Borthwick Kathleen (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
4:17 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
When the levee breaks (Ad) The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point.
In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks. Click here to watch the urgent broadcast and get ahead of what’s coming. |
01/08/2025
5:09 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:05 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:34 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:31 PM | ORBIMED ADVISORS LLC (Filed by)
Passage Bio (Subject)
| Form SCHEDULE 13D/A | |
12/11/2024
4:32 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
6:07 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
5:11 PM | Lynx1 Capital Management LP (Reporting)
Nichols Weston (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
4:21 PM | Erste Asset Management GmbH (Filed by)
Passage Bio (Subject)
| Form SCHEDULE 13G/A | |
11/13/2024
6:15 AM | Passage Bio (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
3:41 PM | Cale Edgar B. (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
3:51 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
5:38 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Passage Bio (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:36 PM | ORBIMED ADVISORS LLC (Reporting)
Passage Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
7:38 PM | ORBIMED CAPITAL LLC (Reporting)
Passage Bio (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
6:00 AM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
3:15 PM | Passage Bio (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access